non-small cell lung cancersFDAEuropean Medicines AgencyFood and Drug Administration
… and 2024, analysing 128 trials in breast, gastrointestinal and non-small cell lung cancers.For each drug, the authors assessed the presence of PRO informa…
6articles mentioning diseases
6disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: Non-small cell lung cancers ×
Non-small cell lung cancers
This disease is selected. Its supporting articles are shown below.
Articles mentioning Non-small cell lung cancers
6 articles · page 1 of 1NSCLCmCRCCRCBCnon-small cell lung cancersnon-small cell lung cancer
…I; and the American Lung Association and Lung Cancer Europe for NSCLC. Selection of patient-advocacy organisations was guided by thre…
breast cancersnon-small cell lung cancersHER2-driven cancerstrastuzumab emtansineChampions OncologystaurosporineHER2-targeting ADCs
…t in oncology, with alterations present in approximately 30% of breast cancers and 20% of non-small cell lung cancers. These alterations—rangi…
NSCLCnon-small cell lung cancersWZB117BAY-876ipilimumab2-deoxy-D-glucose
…targetable barrier to immune infiltration in genetically ‘cold’ NSCLC. Pharmacologic GLUT1 inhibition reprograms the tumor microenvir…
NSCLCnon-small cell lung cancersSTK11-mutant, locally advanced or metastatic solid tumorsTNG260pembrolizumab
…ted clinical activity was observed in patients with KRAS mutant NSCLC and in other solid tumors.Conclusions TNG260 in combination wit…
Non-small cell lung cancersNSCLCsbevacizumabChinese Academy of Medical Sciences Cancer HospitalShanxi Cancer Hospitalplatinum-based chemotherapy
…Background Non-small cell lung cancers (NSCLCs) harboring ROS1 rearranged, RET rearranged, or BRAF V60…